BIIB: Volume dana dhuwit perusahaan Biogen

Simbol lan logo merek Biogen Inc (BIIB)

The cash balance from the GURU.Markets terminal is illustrated by this chart, where the indicator remains around 1.30, confirming margin stability during the drug portfolio transition. Biogen Inc. (BIIB) leverages its vast experience in brain therapy to fund the search for breakthrough solutions. Expansion into the SMA and Alzheimer's disease segments defines the growth potential for Biogen Inc. (BIIB) in the global market.

BIIB - Aset likuid perusahaan Biogen Inc ing rentang 04.07.2022 - 21.11.2026

Biogen (BIIB) - rincian metrik lan laporan keuangan

- kuotasi lan prakiraan analis:
Analisis kabeh metrik perusahaan:Biogen Idec BIIB
Produk mawa merek biogen.com

For Biogen Inc. (BIIB), the volume of liquid assets is a critical resource as the company shifts its market focus from sclerosis medications to innovations in Alzheimer's disease therapy. This cash balance trend captures the total amount of cash and equivalents, allowing for a real-time assessment of actual solvency. The growth of this metric confirms a financial reserve for expansion into new markets; however, excessive stagnation of funds signals issues regarding capital allocation efficiency.

Analisis perusahaan pesaing

Volume dana dhuwit perusahaan NBIX|RGC - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Axsome Therapeutics AXSM|Volume dana dhuwit perusahaan ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Viking Therapeutics|SUPN: Volume dana dhuwit perusahaan|Catalyst Pharmaceuticals (CPRX) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan DNLI|Dhuwit awis lan setara dhuwit awis perusahaan HRMY (Harmony Biosciences Holdings, Inc.)|Dana dhuwit perusahaan Biohaven Ltd. (BHVN)|Gunggung dana dhuwit perusahaan AMLX|Dana dhuwit perusahaan trevitherapeutics.com TRVI|PRAX - Dhuwit awis perusahaan|Anavex Life Sciences Corp - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan CeriBell Corp|Prothena Corporation PLC (PRTA) - Dana dhuwit perusahaan|Alector Therapeutics - Sisa dhuwit perusahaan|Dana dhuwit perusahaan Annexon Biosciences|Cadangan dhuwit perusahaan omeros.com OMER|Dana dhuwit perusahaan Neurogene (NGNE)|Aset likuid perusahaan AC Immune S.A.|Volume dana dhuwit perusahaan VYGR (Voyager Therapeutics Inc)|Sisa dhuwit perusahaan NMRA|scilexholding.com - Volume dana dhuwit perusahaan|TVGN (tevogen.com) - Dhuwit awis lan setara dhuwit awis perusahaan|ACOG: Volume dana dhuwit perusahaan|CGTX: Gunggung dana dhuwit perusahaan|Dana dhuwit perusahaan Inhibikase Therapeutics|Dhuwit awis lan setara dhuwit awis perusahaan SAVA (Cassava)|Dana dhuwit perusahaan Assertio Therapeutics (ASRT)|Coya Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|VistaGen Therapeutics, Inc. - Dhuwit awis perusahaan|ovidrx.com (OVID) - Cadangan dhuwit perusahaan|ABOS: Dhuwit awis perusahaan|Cadangan dhuwit perusahaan CervoMed Inc|alteritytherapeutics.com (ATHE) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Clene Nanomedicine|Dhuwit awis perusahaan PEPG|Cadangan dhuwit perusahaan Jupiter Neurosciences JUNS|Dana dhuwit perusahaan Relmada (RLMD)|Aset likuid perusahaan Annovis Bio, Inc.|Volume dana dhuwit perusahaan GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cadangan dhuwit perusahaan|KLTO - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan NeuroSense Therapeutics Ltd|RVPH: Volume dana dhuwit perusahaan|MetaVia, Inc. (MTVA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan NeurAxis|Volume dana dhuwit perusahaan heliusmedical.com|Dhuwit awis perusahaan PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Minerva Neurosciences Corp - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ATHA|ADXN - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan PTIX|KTTA (pasitheaclinics.com) - Volume dana dhuwit perusahaan|CRGT (cortigent.com) - Gunggung dana dhuwit perusahaan|Volume dana dhuwit perusahaan ATXI|Dana dhuwit perusahaan BCLI (Brainstorm Cell)|Volume dana dhuwit perusahaan CARA (Cara Therapeutics Inc)|Sisa dhuwit perusahaan CHRO|Eliem Therapeutics Inc. - Volume dana dhuwit perusahaan|ITCI - Volume dana dhuwit perusahaan|Longboard Pharma (LBPH) - Dana dhuwit perusahaan|Dhuwit awis perusahaan Marinus Pharmaceuticals|Dana dhuwit perusahaan NKGen|Volume dana dhuwit perusahaan NeuroBo Pharmaceuticals, Inc.|Volume dana dhuwit perusahaan SAGE|Synaptogenix, Inc - Dhuwit awis lan setara dhuwit awis perusahaan|Dana dhuwit perusahaan Trevena TRVN|Posisi dhuwit perusahaan Vigil Neuroscience|Anew Medical Inc. - Volume dana dhuwit perusahaan|Aset likuid perusahaan Cerevel Therapeutics, Inc. CERE